Neuronetics Inc. (NASDAQ: STIM)
$1.5000
-0.0700 ( -6.25% ) 62.8K
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
Market Data
Open
$1.5000
Previous close
$1.5700
Volume
62.8K
Market cap
$85.59M
Day range
$1.4950 - $1.5910
52 week range
$0.5200 - $5.0699
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Sep 13, 2024 |
4 | Insider transactions | 1 | Sep 06, 2024 |
4 | Insider transactions | 1 | Aug 30, 2024 |
4 | Insider transactions | 1 | Aug 21, 2024 |
4 | Insider transactions | 1 | Aug 19, 2024 |
4 | Insider transactions | 1 | Aug 16, 2024 |
4 | Insider transactions | 1 | Aug 16, 2024 |
8-k | 8K-related | 35 | Aug 15, 2024 |
8-k | 8K-related | 30 | Aug 14, 2024 |
8-k | 8K-related | 18 | Aug 13, 2024 |